T2-TrpRS

N/A

Report date: 2023/02/11 20:38:15

Base Information

Drug NameT2-TrpRS
Drug Alias NameTryptophan tRNA synthetase fragment (EyeCyte)PF-3384611
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEyecyte
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEyecyte
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A